BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9504441)

  • 1. Anti-proliferative effects of lichen-derived inhibitors of 5-lipoxygenase on malignant cell-lines and mitogen-stimulated lymphocytes.
    Ogmundsdóttir HM; Zoëga GM; Gissurarson SR; Ingólfsdóttir K
    J Pharm Pharmacol; 1998 Jan; 50(1):107-15. PubMed ID: 9504441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-proliferative lichen compounds with inhibitory activity on 12(S)-HETE production in human platelets.
    Bucar F; Schneider I; Ogmundsdóttir H; Ingólfsdóttir K
    Phytomedicine; 2004 Nov; 11(7-8):602-6. PubMed ID: 15636173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimycobacterial activity of lichen metabolites in vitro.
    Ingólfsdóttir K; Chung GA; Skúlason VG; Gissurarson SR; Vilhelmsdóttir M
    Eur J Pharm Sci; 1998 Apr; 6(2):141-4. PubMed ID: 9795033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic activity and antioxidant capacity of purified lichen metabolites: an in vitro study.
    Brisdelli F; Perilli M; Sellitri D; Piovano M; Garbarino JA; Nicoletti M; Bozzi A; Amicosante G; Celenza G
    Phytother Res; 2013 Mar; 27(3):431-7. PubMed ID: 22628260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Cancer Activity of Lobaric Acid and Lobarstin Extracted from the Antarctic Lichen Stereocaulon alpnum.
    Hong JM; Suh SS; Kim TK; Kim JE; Han SJ; Youn UJ; Yim JH; Kim IC
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29538328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-proliferative effects of lichen-derived lipoxygenase inhibitors on twelve human cancer cell lines of different tissue origin in vitro.
    Haraldsdóttir S; Guolaugsdóttir E; Ingólfsdóttir K; Ogmundsdóttir HM
    Planta Med; 2004 Nov; 70(11):1098-100. PubMed ID: 15549672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-proliferative and pro-apoptotic effects of lichen-derived compound protolichesterinic acid are not mediated by its lipoxygenase-inhibitory activity.
    Bessadóttir M; Eiríksson FF; Becker S; Ögmundsdóttir MH; Ómarsdóttir S; Thorsteinsdóttir M; Ögmundsdóttir HM
    Prostaglandins Leukot Essent Fatty Acids; 2015 Jul; 98():39-47. PubMed ID: 25964147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total Syntheses of Lobaric Acid and Its Derivatives from the Antarctic Lichen Stereocaulon alpinum.
    Kim TK; Kim JE; Youn UJ; Han SJ; Kim IC; Cho CG; Yim JH
    J Nat Prod; 2018 Jun; 81(6):1460-1467. PubMed ID: 29878768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobaric acid and pseudodepsidones inhibit NF-κB signaling pathway by activation of PPAR-γ.
    Carpentier C; Barbeau X; Azelmat J; Vaillancourt K; Grenier D; Lagüe P; Voyer N
    Bioorg Med Chem; 2018 Dec; 26(22):5845-5851. PubMed ID: 30420328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protolichesterinic Acid, Isolated from the Lichen Cetraria islandica, Reduces LRRC8A Expression and Volume-Sensitive Release of Organic Osmolytes in Human Lung Epithelial Cancer Cells.
    Thorsteinsdottir UA; Thorsteinsdottir M; Lambert IH
    Phytother Res; 2016 Jan; 30(1):97-104. PubMed ID: 26549524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of anti-proliferative lichen metabolite, protolichesterinic acid on fatty acid synthase, cell signalling and drug response in breast cancer cells.
    Bessadóttir M; Skúladóttir EÁ; Gowan S; Eccles S; Ögmundsdóttir S; Ogmundsdóttir HM
    Phytomedicine; 2014 Oct; 21(12):1717-24. PubMed ID: 25442282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vicanicin and protolichesterinic acid on human prostate cancer cells: role of Hsp70 protein.
    Russo A; Caggia S; Piovano M; Garbarino J; Cardile V
    Chem Biol Interact; 2012 Jan; 195(1):1-10. PubMed ID: 22063921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lobaric acid on cysteinyl-leukotriene formation and contractile activity of guinea pig taenia coli.
    Gissurarson SR; Sigurdsson SB; Wagner H; Ingolfsdottir K
    J Pharmacol Exp Ther; 1997 Feb; 280(2):770-3. PubMed ID: 9023290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOS response in bacteria: Inhibitory activity of lichen secondary metabolites against Escherichia coli RecA protein.
    Bellio P; Di Pietro L; Mancini A; Piovano M; Nicoletti M; Brisdelli F; Tondi D; Cendron L; Franceschini N; Amicosante G; Perilli M; Celenza G
    Phytomedicine; 2017 Jun; 29():11-18. PubMed ID: 28515022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of Helicobacter pylori to protolichesterinic acid from the lichen Cetraria islandica.
    Ingolfsdottir K; Hjalmarsdottir MA; Sigurdsson A; Gudjonsdottir GA; Brynjolfsdottir A; Steingrimsson O
    Antimicrob Agents Chemother; 1997 Jan; 41(1):215-7. PubMed ID: 8980785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer activities of selected species of North American lichen extracts.
    Shrestha G; El-Naggar AM; St Clair LL; O'Neill KL
    Phytother Res; 2015 Jan; 29(1):100-7. PubMed ID: 25257119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein tyrosine phosphatase 1B inhibitory effects of depsidone and pseudodepsidone metabolites from the Antarctic lichen Stereocaulon alpinum.
    Seo C; Sohn JH; Ahn JS; Yim JH; Lee HK; Oh H
    Bioorg Med Chem Lett; 2009 May; 19(10):2801-3. PubMed ID: 19362837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectroscopic and photochemical properties of the lichen compound lobaric acid.
    Hidalgo ME; Bascuñan L; Quilhot W; Fernández E; Rubio C
    Photochem Photobiol; 2005; 81(6):1447-9. PubMed ID: 16107188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimitotic activity of lobaric acid and a new benzofuran, sakisacaulon A from Stereocaulon sasakii.
    Morita H; Tsuchiya T; Kishibe K; Noya S; Shiro M; Hirasawa Y
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3679-81. PubMed ID: 19481447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Review of Anti-Cancer and Related Properties of Lichen-Extracts and Metabolites.
    Tripathi AH; Negi N; Gahtori R; Kumari A; Joshi P; Tewari LM; Joshi Y; Bajpai R; Upreti DK; Upadhyay SK
    Anticancer Agents Med Chem; 2022; 22(1):115-142. PubMed ID: 34225637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.